Myeloma cells exhibit an increase in proteasome activity and an enhanced response to proteasome inhibition in the bone marrow microenvironment in vivo.
The proteasome inhibitor bortezomib has a striking clinical benefit in patients with multiple myeloma. It is unknown whether the bone marrow microenvironment directly contributes to the dramatic response of myeloma cells to proteasome inhibition in vivo. We have used the well-characterized 5TGM1 mur...
| मुख्य लेखकों: | , , , , , , |
|---|---|
| स्वरूप: | Journal article |
| भाषा: | English |
| प्रकाशित: |
2009
|
| _version_ | 1826298014372724736 |
|---|---|
| author | Edwards, C Lwin, S Fowler, J Oyajobi, B Zhuang, J Bates, A Mundy, G |
| author_facet | Edwards, C Lwin, S Fowler, J Oyajobi, B Zhuang, J Bates, A Mundy, G |
| author_sort | Edwards, C |
| collection | OXFORD |
| description | The proteasome inhibitor bortezomib has a striking clinical benefit in patients with multiple myeloma. It is unknown whether the bone marrow microenvironment directly contributes to the dramatic response of myeloma cells to proteasome inhibition in vivo. We have used the well-characterized 5TGM1 murine model of myeloma to investigate myeloma growth within bone and response to the proteasome inhibitor bortezomib in vivo. Myeloma cells freshly isolated from the bone marrow of myeloma-bearing mice were found to have an increase in proteasome activity and an enhanced response to in vitro proteasome inhibition, as compared with pre-inoculation myeloma cells. Treatment of myeloma-bearing mice with bortezomib resulted in a greater reduction in tumor burden when the myeloma cells were located within the bone marrow when compared with extra-osseous sites. Our results demonstrate that myeloma cells exhibit an increase in proteasome activity and an enhanced response to bortezomib treatment when located within the bone marrow microenvironment in vivo. |
| first_indexed | 2024-03-07T04:40:21Z |
| format | Journal article |
| id | oxford-uuid:d1699da9-5977-4709-aa9a-d46e0d039d1d |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T04:40:21Z |
| publishDate | 2009 |
| record_format | dspace |
| spelling | oxford-uuid:d1699da9-5977-4709-aa9a-d46e0d039d1d2022-03-27T07:56:51ZMyeloma cells exhibit an increase in proteasome activity and an enhanced response to proteasome inhibition in the bone marrow microenvironment in vivo.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:d1699da9-5977-4709-aa9a-d46e0d039d1dEnglishSymplectic Elements at Oxford2009Edwards, CLwin, SFowler, JOyajobi, BZhuang, JBates, AMundy, GThe proteasome inhibitor bortezomib has a striking clinical benefit in patients with multiple myeloma. It is unknown whether the bone marrow microenvironment directly contributes to the dramatic response of myeloma cells to proteasome inhibition in vivo. We have used the well-characterized 5TGM1 murine model of myeloma to investigate myeloma growth within bone and response to the proteasome inhibitor bortezomib in vivo. Myeloma cells freshly isolated from the bone marrow of myeloma-bearing mice were found to have an increase in proteasome activity and an enhanced response to in vitro proteasome inhibition, as compared with pre-inoculation myeloma cells. Treatment of myeloma-bearing mice with bortezomib resulted in a greater reduction in tumor burden when the myeloma cells were located within the bone marrow when compared with extra-osseous sites. Our results demonstrate that myeloma cells exhibit an increase in proteasome activity and an enhanced response to bortezomib treatment when located within the bone marrow microenvironment in vivo. |
| spellingShingle | Edwards, C Lwin, S Fowler, J Oyajobi, B Zhuang, J Bates, A Mundy, G Myeloma cells exhibit an increase in proteasome activity and an enhanced response to proteasome inhibition in the bone marrow microenvironment in vivo. |
| title | Myeloma cells exhibit an increase in proteasome activity and an enhanced response to proteasome inhibition in the bone marrow microenvironment in vivo. |
| title_full | Myeloma cells exhibit an increase in proteasome activity and an enhanced response to proteasome inhibition in the bone marrow microenvironment in vivo. |
| title_fullStr | Myeloma cells exhibit an increase in proteasome activity and an enhanced response to proteasome inhibition in the bone marrow microenvironment in vivo. |
| title_full_unstemmed | Myeloma cells exhibit an increase in proteasome activity and an enhanced response to proteasome inhibition in the bone marrow microenvironment in vivo. |
| title_short | Myeloma cells exhibit an increase in proteasome activity and an enhanced response to proteasome inhibition in the bone marrow microenvironment in vivo. |
| title_sort | myeloma cells exhibit an increase in proteasome activity and an enhanced response to proteasome inhibition in the bone marrow microenvironment in vivo |
| work_keys_str_mv | AT edwardsc myelomacellsexhibitanincreaseinproteasomeactivityandanenhancedresponsetoproteasomeinhibitioninthebonemarrowmicroenvironmentinvivo AT lwins myelomacellsexhibitanincreaseinproteasomeactivityandanenhancedresponsetoproteasomeinhibitioninthebonemarrowmicroenvironmentinvivo AT fowlerj myelomacellsexhibitanincreaseinproteasomeactivityandanenhancedresponsetoproteasomeinhibitioninthebonemarrowmicroenvironmentinvivo AT oyajobib myelomacellsexhibitanincreaseinproteasomeactivityandanenhancedresponsetoproteasomeinhibitioninthebonemarrowmicroenvironmentinvivo AT zhuangj myelomacellsexhibitanincreaseinproteasomeactivityandanenhancedresponsetoproteasomeinhibitioninthebonemarrowmicroenvironmentinvivo AT batesa myelomacellsexhibitanincreaseinproteasomeactivityandanenhancedresponsetoproteasomeinhibitioninthebonemarrowmicroenvironmentinvivo AT mundyg myelomacellsexhibitanincreaseinproteasomeactivityandanenhancedresponsetoproteasomeinhibitioninthebonemarrowmicroenvironmentinvivo |